Cue Biopharma grants equity to Chief Medical Officer
Cue Biopharma, Inc. granted its Chief Medical Officer and Head of Research & Development, Dominique Christian Borie, 31,500 restricted stock units (RSUs) and stock options for 63,000 shares of common stock.
Rhea-AI Filing Summary
Cue Biopharma, Inc. granted its Chief Medical Officer and Head of Research & Development, Dominique Christian Borie, 31,500 restricted stock units (RSUs) and stock options for 63,000 shares of common stock. The options carry an exercise price of $30.9200 per share and expire on July 13, 2036.
The RSUs and options each vest in equal quarterly installments over four years starting July 13, 2026, contingent on Borie’s continued service with the company. Following these grants, Borie holds 31,500 common shares and options on 63,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 94,500 shares
Grant/Award
2 txns
Insider
Borie Dominique Christian
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 63,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 31,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 63,000 contracts (Direct);
Common Stock — 31,500 shares (Direct)
Footnotes (2)
- F1. Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest in equal quarterly installments over four years from July 13, 2026, subject to the reporting person's continued service with the issuer through each vest date.
- F2. The stock option becomes exercisable in equal quarterly installments over four years from July 13, 2026, subject to the reporting person's continued service with the issuer through each vest date.
Key Figures
RSUs granted: 31,500 shares
Stock options granted: 63,000 shares
Option exercise price: $30.9200 per share
+2 more
5 metrics
RSUs granted
31,500 shares
Restricted stock units granted to the Chief Medical Officer on July 13, 2026
Stock options granted
63,000 shares
Options on Cue Biopharma common stock granted July 13, 2026
Option exercise price
$30.9200 per share
Exercise price for the 63,000 stock options granted to Borie
Option expiration date
2036-07-13
Expiration date for the stock options granted to Borie
Vesting schedule
Four years, quarterly installments
RSUs and options vest in equal quarterly installments over four years from July 13, 2026
Key Terms
restricted stock units, RSUs, stock option, exercisable, +1 more
5 terms
restricted stock units financial
"Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
stock option financial
"The stock option becomes exercisable in equal quarterly installments over four years"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercisable financial
"The stock option becomes exercisable in equal quarterly installments over four years"
vest financial
"The shares subject to the RSU vest in equal quarterly installments over four years"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What equity awards did Cue Biopharma (CUE) grant to Dominique Christian Borie?
Cue Biopharma granted Dominique Christian Borie 31,500 RSUs and stock options for 63,000 common shares. The options have a $30.9200 exercise price and expire on July 13, 2036, forming part of his executive equity compensation package.
How do the Cue Biopharma (CUE) RSUs granted to Borie vest?
The 31,500 RSUs vest in equal quarterly installments over four years starting July 13, 2026. Each installment is contingent on Borie’s continued service with Cue Biopharma through the applicable vesting date.
What are the key terms of Borie’s Cue Biopharma (CUE) stock options?
Borie received options for 63,000 shares of Cue Biopharma common stock at a $30.9200 exercise price, expiring on July 13, 2036. The options become exercisable in equal quarterly installments over four years from July 13, 2026.
Are Borie’s Cue Biopharma (CUE) equity awards tied to continued employment?
Yes. Both the 31,500 RSUs and the options on 63,000 shares vest or become exercisable only if Borie continues serving Cue Biopharma through each quarterly vesting date over the four-year schedule beginning July 13, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
